Raymond Debbane

@Siren, L.l.c.

Latest period2024 - Q3

Reported2mo 6d ago

Managed Assets$2B

Total holdings110

Assets growth rate0%

Assets growth rate (2-Q avg)0%

Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Siren, L.l.c.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 110 positions.

Assets under management

The assets under management (AUM) of Siren, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2B in assets, with a quarterly growth rate of 0% and a 2-quarter average growth rate of 0%. The portfolio is managed by Raymond Debbane, and others.

Portfolio holdings

Current New Position Increased Decreased Exited

Investment	Portfolio %	Reported Value	Recent Activity
RAPPRapport Therapeutics Inc Recent Activity New Position	0.4%	$7.868M 384,197 shares@ $20.49 avg price	New Position
NGNENeurogene Inc Recent Activity New Position	0.37%	$7.381M 175,898 shares@ $41.96 avg price	New Position
GBIOGeneration Bio Co Recent Activity New Position	0.37%	$7.367M 2.983M shares@ $2.48 avg price	New Position
IHSIhs Holding Limited Recent Activity New Position	0.36%	$7.049M 2.358M shares@ $3.0 avg price	New Position
CRWDCrowdstrike Holdings Inc Recent Activity New Position	0.36%	$7.012M 25,000 shares@ $280.47 avg price	New Position
VIGLVigil Neuroscience Inc Recent Activity New Position	0.34%	$6.77M 1.991M shares@ $3.4 avg price	New Position
FHTXFoghorn Therapeutics Inc. Recent Activity New Position	0.34%	$6.71M 720,720 shares@ $9.31 avg price	New Position
NOWServicenow Inc Recent Activity New Position	0.34%	$6.708M 7,500 shares@ $894.39 avg price	New Position
AMZNAmazon.com Inc Recent Activity New Position	0.33%	$6.475M 34,750 shares@ $186.34 avg price	New Position
BIOABioage Labs Inc Recent Activity New Position	0.32%	$6.24M 300,000 shares@ $20.8 avg price	New Position